Association Between Health Insurance Coverage and Stage of Diagnosis for Cervical Cancer Among Females in Indiana from 2011 - 2019

Overview

Journal Prev Med Rep

Date 2025 Feb 3

PMID 39897738

Authors

Mrithula Suresh Babu

Monica L Kasting

Natalia M Rodriguez

Affiliations

Soon will be listed here.

Abstract

Introduction: Health insurance status is an important determinant of health outcomes for patients with cancer. This study aimed to assess the extent to which health insurance coverage in Indiana is a contributing factor to the stage of cervical cancer diagnosis.

Methods: We examined reported cervical cancer cases among females ( = 2518) using cancer registry data from the Indiana Department of Health from 2011 to 2019. Analyses were carried out in SPSS. Using multinomial logistic regression, we examined associations of both insurance status and race/ethnicity with stage of diagnosis after adjusting for age at diagnosis.

Results: The multinomial analysis showed that uninsured females (OR = 2.42, 95 % CI = 1.35-4.35) and those who have Medicaid (OR = 2.36, 95 % CI = 1.62-3.42) were significantly more likely to be diagnosed at the regional stage than the in-situ stage compared to females with private insurance. Additionally, Black (OR = 1.98, 95 % CI = 1.21-3.24) and Hispanic females (OR = 2.19, 95 %CI = 1.04-4.61) were significantly more likely to be diagnosed at the regional stage than the in-situ stage when compared to Non-Hispanic White females. Females who are uninsured (OR = 4.43, 95 % CI = 2.23-8.44) and those who have Medicaid (OR = 3.03, 95 % CI = 1.91-4.80) were significantly more likely to be diagnosed at the distant stage than in-situ, compared to females with private insurance.

Conclusion: Insurance status and race/ethnicity are associated with later stages of cervical cancer diagnosis. Increased coverage for routine cervical cancer screening and preventive care services is recommended, especially for racial/ethnic minority populations, the uninsured and those with public insurance.

References

Star J, Bandi P, Siegel R, Han X, Minihan A, Smith R . Cancer Screening in the United States During the Second Year of the COVID-19 Pandemic. J Clin Oncol. 2023; 41(27):4352-4359. PMC: 10911528. DOI: 10.1200/JCO.22.02170. View

Yu L, Sabatino S, White M . Rural-Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010-2014. Prev Chronic Dis. 2019; 16:E70. PMC: 6583816. DOI: 10.5888/pcd16.180447. View

Gravitt P, Winer R . Natural History of HPV Infection across the Lifespan: Role of Viral Latency. Viruses. 2017; 9(10). PMC: 5691619. DOI: 10.3390/v9100267. View

Qi L, Wang M, Jia Y, Wang Y, Xue L, Du L . Impact of the COVID-19 pandemic on the hospital attendance of patients with primary cervical cancer in Heilongjiang, China. Int J Cancer. 2023; 153(6):1172-1181. DOI: 10.1002/ijc.34617. View

Hariri S, Unger E, Powell S, Bauer H, Bennett N, Bloch K . The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions. Cancer Causes Control. 2011; 23(2):281-8. DOI: 10.1007/s10552-011-9877-6. View

Ko N, Hong S, Winn R, Calip G . Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer. JAMA Oncol. 2020; 6(3):385-392. PMC: 6990828. DOI: 10.1001/jamaoncol.2019.5672. View

Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J . Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2019; 8(2):e191-e203. PMC: 7025157. DOI: 10.1016/S2214-109X(19)30482-6. View

Wright J, Chen L, Tergas A, Burke W, Hou J, Neugut A . Population-level trends in relative survival for cervical cancer. Am J Obstet Gynecol. 2015; 213(5):670.e1-7. PMC: 4631664. DOI: 10.1016/j.ajog.2015.07.012. View

Riley G, Potosky A, Lubitz J, Brown M . Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health. 1994; 84(10):1598-604. PMC: 1615068. DOI: 10.2105/ajph.84.10.1598. View

10.

Spada N, Geramita E, Zamanian M, van Londen G, Sun Z, Sabik L . Changes in Disparities in Stage of Breast Cancer Diagnosis in Pennsylvania After the Affordable Care Act. J Womens Health (Larchmt). 2020; 30(3):324-331. PMC: 7957377. DOI: 10.1089/jwh.2020.8478. View

11.

Pirani N, Jafari M, Bagherzadeh R, Keikhosravi M, Pirani H . Cervical Cancer Prevention, Its Challenges and Solutions in Iran and Worldwide: A Systematic Review. Iran J Public Health. 2023; 52(11):2313-2324. PMC: 10719694. DOI: 10.18502/ijph.v52i11.14031. View

12.

Saraiya M, Unger E, Thompson T, Lynch C, Hernandez B, Lyu C . US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015; 107(6):djv086. PMC: 4838063. DOI: 10.1093/jnci/djv086. View

13.

Puricelli Perin D, Elfstrom K, Bulliard J, Buron A, Campbell C, Flugelman A . Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey. Prev Med. 2021; 151:106642. PMC: 8241661. DOI: 10.1016/j.ypmed.2021.106642. View

14.

Adams S, Fleming A, Brandt H, Hurley D, Bolick-Aldrich S, Bond S . Racial disparities in cervical cancer mortality in an African American and European American cohort in South Carolina. J S C Med Assoc. 2010; 105(7):237-44. PMC: 2966141. View

15.

Siegel R, Ward E, Brawley O, Jemal A . Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4):212-36. DOI: 10.3322/caac.20121. View

16.

Carmen M, Avila-Wallace M . Effect of health care disparities on screening. Clin Obstet Gynecol. 2013; 56(1):65-75. DOI: 10.1097/GRF.0b013e31827af75a. View

17.

Davies J, Spencer A, Macdonald S, Dobson L, Haydock E, Burton H . Cervical cancer and COVID-an assessment of the initial effect of the pandemic and subsequent projection of impact for women in England: A cohort study. BJOG. 2022; 129(7):1133-1139. PMC: 9303941. DOI: 10.1111/1471-0528.17098. View

18.

Rauh-Hain J, Clemmer J, Bradford L, Clark R, Growdon W, Goodman A . Racial disparities in cervical cancer survival over time. Cancer. 2013; 119(20):3644-52. DOI: 10.1002/cncr.28261. View

19.

Halpern M, Ward E, Pavluck A, Schrag N, Bian J, Chen A . Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008; 9(3):222-31. DOI: 10.1016/S1470-2045(08)70032-9. View

20.

Ward E, Fedewa S, Cokkinides V, Virgo K . The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer J. 2010; 16(6):614-21. DOI: 10.1097/PPO.0b013e3181ff2aec. View